Dongfang Biological: Net loss of 1.15 billion yuan in the first quarter of 2025.

Oriental biology announced that the revenue in the first quarter of 2025 was 192 million yuan, an increase of 4.94% year-on-year; net loss was 115 million yuan, compared to a net loss of 67.35 million yuan in the same period last year.